GBT Description — Global Blood Therapeutics Inc

Global Blood Therapeutics is a clinical-stage biopharmaceutical company determined to discover, develop and deliver treatments that provide hope to underserved patient communities. Co.'s primary product candidate is voxelotor, an oral, once-daily therapy that modulates hemoglobin's affinity for oxygen, which inhibits hemoglobin polymerization in sickle cell disease (SCD). Co. is evaluating voxelotor in adult and adolescent patients with SCD in a Phase 3 clinical trial. Co. is also evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in adolescent and pediatric patients with SCD in a Phase 2a clinical trial.

Company Name: 
Global Blood Therapeutics Inc
Drugs & Pharmaceuticals
Number of ETFs Holding GBT: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   GBT Weight   GBT Amount 
 VTI   0.01%   $82,117,175         
 VB   0.10%   $74,363,058         
 IWM   0.20%   $68,641,829         
 VXF   0.08%   $43,645,174         
 VBK   0.21%   $43,635,718         
 IBB   0.42%   $27,677,347         
 IWO   0.36%   $25,839,328         
 VHT   0.08%   $7,974,101         
 VTWO   0.19%   $3,326,715         
 ITOT   0.01%   $2,493,905         
List of all 27 ETFs holding GBT »
Quotes delayed 20 minutes

Strong Buy (3.57 out of 4)
68th percentile
(ranked higher than approx. 68% of all stocks covered)

Analysts Forecast:
GBT Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding GBT | Global Blood Therapeutics Inc | ETF Channel |

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.